Fundraising FoxOliPass Venture Capital
2 known investors
Find your way into OliPass Venture Capital
Sign up to see every warm intro you have to OliPass Venture Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OliPass Venture Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OliPass develops an antisense oligonucleotide drug-discovery platform based on its chemically modified peptide nucleic acid technology, which improves cell permeability to enable exon-skipping therapeutics. It targets pre-mRNA to generate new drug candidates for therapeutic development.
Investors · 2
▸Research sources · 1
primary sources listed
- Healthcare automation company Olive is shutting downfiercehealthcare.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does OliPass Venture Capital do?
- OliPass develops an antisense oligonucleotide drug-discovery platform based on its chemically modified peptide nucleic acid technology, which improves cell permeability to enable exon-skipping therapeutics. It targets pre-mRNA to generate new drug candidates for therapeutic development.
- Who are OliPass Venture Capital's investors?
- OliPass Venture Capital's investors include IMM Investment Japan, Kiwoom Investment.